Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Secondary Surfactant Deficiency in Neonates

Journal of Perinatology volume 24, pages 663–666 (2004)Cite this article

Abstract

Surfactant treatment has become the standard of care in premature infants with respiratory distress syndrome (RDS). Pulmonary hemorrhage, pulmonary edema, pneumonia, and atelectasis have been shown to liberate inflammatory mediators and plasma proteins, which damage type II pneumocytes and inactivate surfactant. These disease processes may, therefore, lead to a secondary surfactant inactivation or deficiency, which can be an unrecognized cause of respiratory decompensation after initial recovery from RDS in this vulnerable population. This is a descriptive report of three cases, which had acute respiratory decompensation between 1 and 3 weeks of age. All three infants demonstrated a response to secondary doses of surfactant. We submit that the diagnosis and treatment of secondary surfactant deficiency in the critically ill premature neonate warrants further study.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Graph 1
Graph 2
Graph 3

Similar content being viewed by others

References

  1. Jobe AH . Pathophysiology of respiratory distress syndrome. In: Polin RA, Fox WW, editors. Fetal and Neonatal Physiology. Vol. 2. Philadelphia: WB Saunders Company; 1992 p. 995–1001.

    Google Scholar 

  2. Taeusch HW . Treatment of acute (adult) respiratory distress syndrome. The Holy Grail of surfactant therapy. Biol Neonate 2000;77(Suppl 1):2–8.

    Article  CAS  Google Scholar 

  3. Harms K, Herting E . Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia. Respiration 1994;61:348–352.

    Article  CAS  Google Scholar 

  4. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B, Members of the Collaborative European Multicenter Study Group. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000;106(5):957–965.

    Article  CAS  Google Scholar 

  5. Lopez-Herce J, de Lucas N, Carrillo A, Bustinza A, Moral R . Surfactant treatment for acute respiratory distress syndrome. Arch Dis Child 1999;80:248–252.

    Article  CAS  Google Scholar 

  6. Moreno M, Lopez-Herce J, Alcaraz A, Carrillo A . Exogenous surfactant therapy for acute respiratory distress in infancy. Intens Care Med 1996;22:87–88.

    Article  CAS  Google Scholar 

  7. Perez-Benavides F, Riff E, Franks C . Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient. Pediatr Emerg Care 1995;11(3):153–155.

    Article  CAS  Google Scholar 

  8. Wilson DF, Jiao JH, Bauman LA, et al. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit Care Med 1996;24(6):1316–1322.

    Article  Google Scholar 

  9. Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL . Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 1991;87(1):101–107.

    CAS  PubMed  Google Scholar 

  10. Findlay R, Tauesch W, Walther F . Surfactant replacement therapy for meconium aspiration syndrome. Pediatrics 1996;97(1):48–52.

    CAS  PubMed  Google Scholar 

  11. Thibeault DW, Maabry SM, Ekekezie II, Truog WE . Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 2000;106(6):1452–1459.

    Article  CAS  Google Scholar 

  12. Nishina K, Mikawa K, Takao Y, Maekawa N, Obara H . Effects of exogenous surfactant on acute lung injury induced by intratracheal instillation of infant formula or human breast milk in rabbits. Anesthesiology 1999;91:240–252.

    Article  CAS  Google Scholar 

  13. Kazzi SNJ, Schurch S, McLaughlin KL, Romero R, Janissee J . Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia. Acta Paediatr 2000;89:1218–1225.

    Article  CAS  Google Scholar 

  14. Davis JM, Richter SE, Kendig JW, Notter RH . High-frequency jet ventilation and surfactant treatment of newborns with severe respiratory failure. Pediatr Pulmonol 1992;13:108–112.

    Article  CAS  Google Scholar 

  15. Pandit PB, Dunn MS, Kelly EN, Perlman M . Surfactant replacement in neonates with early chronic lung disease. Pediatrics 1995;95:851–854.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Nursing, Medical University of South Carolina, SC, USA

    Robin Bissinger MSN, RNC, NNP, Cheryl Carlson MS, RNC, NNP, Tom Hulsey ScD & Dorothea Eicher MD

Authors
  1. Robin Bissinger MSN, RNC, NNP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cheryl Carlson MS, RNC, NNP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tom Hulsey ScD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dorothea Eicher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bissinger, R., Carlson, C., Hulsey, T. et al. Secondary Surfactant Deficiency in Neonates. J Perinatol 24, 663–666 (2004). https://doi.org/10.1038/sj.jp.7211154

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211154

This article is cited by

Search

Advanced search

Quick links